The new EU medical devices and In Vitro diagnostic regulations are poised to reshape the European medical devices industry, introducing additional hurdles for manufacturing, promoting and selling innovative products. Small and medium sized medtech enterprises must consider their legal and business strategies to ensure a seamless transition and continued access in the marketplace.
To help Swiss medtech companies map their approach, we will be hosting an afternoon of interactive discussions. Our respected panel of speakers (including a representative of the EU Commission) will cover a variety of topics related to the regulations, sharing tips and best practices for the challenges and opportunities that lie ahead for Swiss medtech enterprises.
- Update and Thoughts from Regulators
- Own Brand Labeling
- The Future for SMEs Under MDR/IVDR
- Consolidation Opportunities
- The Rise of e-Health
Click here to view agenda.
For more information or questions, please contact firstname.lastname@example.org.
The event is open to representatives of medtech companies with a strategic role as well as PE investors but also to representatives of life sciences companies in general. There is no registration fee to attend this event. Due to space limitations for this event, registrations will be confirmed by email.